Amstelland Hospital in the Netherlands Selects Sectra’s Subscription Model for Enterprise Imaging to Improve Efficiency & Patient Care

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with Amstelland Hospital in the Netherlands. The hospital’s radiology department will be using Sectra’s enterprise imaging solution as a subscription (Sectra One). It will enable future scalability as imaging volumes grow, as well as the possibility of expanding into other specialties.

“It will support us in shaping the digital future of our hospital as it allows us to easily expand to other medical specialties and departments. The solution will also streamline our radiologists’ workflow, provide them with user-friendly tools and enable them to collaborate more effectively to ultimately deliver better patient care. The proven high quality and good service were other important aspects when we chose Sectra,” Dr. Jasper Sluimer, Radiologist and Chief Medical Information Officer at Amstelland Hospital, says and continues: “Our mission is to provide high-quality medical treatments and customer care, provided by motivated staff. The digitalization of healthcare is important for the future; therefore, we are excited about partnering with Sectra and the implementation of their enterprise imaging solution at our hospital.”

Amstelland Hospital is a general hospital located in Amstelveen, the Netherlands. It offers a wide range of medical services, including emergency care, surgery, radiology, cardiology, and rehabilitation. The hospital has over 200 beds and employs around 1,100 healthcare professionals.

The contract, signed in June 2023, provides Sectra’s enterprise imaging solution as a subscription (Sectra One) and Amstelland Hospital will initially implement the radiology and breast imaging software modules.

Sectra’s enterprise imaging solution will provide radiologists with tools that allow them to easily share images and information within their team and between departments. By utilizing a single platform, they will be able to collaborate more easily and work with patients more efficiently.

“Partnering with Amstelland and providing them with Sectra One makes me proud. Our subscription model offers them the flexibility to scale their imaging solution, ensuring that they can continue to provide high-quality care to their patients while adapting to the changing healthcare landscape,” says Peter Osinga, Managing Director, Sectra Benelux and DACH.

Sectra’s enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in “Best in KLAS“.

SourceSectra
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version